Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies S.A.
  6. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES S.A.

(DBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
04/19/2021 04/20/2021 04/21/2021 04/22/2021 04/23/2021 Date
10.14(c) 9.866(c) 10.32(c) 10.23(c) 10.09 Last
451 052 413 063 301 555 197 400 246 829 Volume
-2.59% -2.70% +4.60% -0.87% -1.37% Change
More quotes
Financials
Sales 2021 15,2 M 18,3 M 18,3 M
Net income 2021 -132 M -158 M -158 M
Net cash position 2021 85,1 M 102 M 102 M
P/E ratio 2021 -3,88x
Yield 2021 -
Sales 2022 50,6 M 60,9 M 60,9 M
Net income 2022 -112 M -134 M -134 M
Net cash position 2022 115 M 138 M 138 M
P/E ratio 2022 -6,10x
Yield 2022 -
Capitalization 561 M 674 M 675 M
EV / Sales 2021 31,4x
EV / Sales 2022 8,82x
Nbr of Employees 142
Free-Float 92,1%
More Financials
Company
DBV Technologies S.A. specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin. 
Sector
Pharmaceuticals
Calendar
05/03Earnings Release
More about the company
Notations Surperformance© of DBV Technologies S.A.
Trading Rating : Investor Rating :
More Ratings
All news about DBV TECHNOLOGIES S.A.
04/16European ADRs Move Higher in Friday Trading
MT
04/16EGG ALLERGY PIPELINE : Emerging Therapies and Key pharma players involved by Del..
AQ
04/14European ADRs Move Higher in Wednesday Trading
MT
04/13European ADRs Move Lower in Tuesday Trading
MT
04/08European ADRs Move Higher in Thursday Trading
MT
04/07European ADRs Move Higher in Wednesday Trading
MT
04/05DBV TECHNOLOGIES  : Announces Appointment of Timothy E. Morris to Board of Direc..
AQ
04/02DBV TECHNOLOGIES S.A.  : Change in Directors or Principal Officers, Regulation F..
AQ
04/02DBV Technologies Announces Appointment of Timothy E. Morris to Board of Direc..
GL
04/02DBV TECHNOLOGIES S.A.  : Nomination
CO
03/29DBV TECHNOLOGIES  : Announces a New Chair of its Audit Committee and Date of its..
AQ
03/26DBV TECHNOLOGIES S.A.  : Change in Directors or Principal Officers, Regulation F..
AQ
03/26DBV TECHNOLOGIES  : Announces a New Chair of its Audit Committee and Date of its..
GL
03/26DBV Technologies Announces a New Chair of its Audit Committee and Date of its..
GL
03/26DBV TECHNOLOGIES S.A.  : Nomination
CO
More news
News in other languages on DBV TECHNOLOGIES S.A.
04/19DBV TECHNOLOGIES S A  : AGM 2021 – Rapport du Conseil d'Administration à l..
04/16DBV TECHNOLOGIES  : plus forte baisse du SBF 120 à la clôture du vendredi 16 avr..
04/16DBV TECHNOLOGIES  : plus forte baisse du SRD à la clôture du vendredi 16 avril 2..
04/14DBV TECHNOLOGIES S A  : AGM 2021 – Avis Préalable à l'Assemblée Générale
04/06STOCK MARKET PARIS : Le mois d'avril démarre fort
More news
Chart DBV TECHNOLOGIES S.A.
Duration : Period :
DBV Technologies S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES S.A.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 4
Average target price 8,80 €
Last Close Price 10,23 €
Spread / Highest target 7,53%
Spread / Average Target -14,0%
Spread / Lowest Target -26,7%
EPS Revisions
Managers and Directors
NameTitle
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Bertrand Dupont Chief Technology Officer
Pharis Mohideen Chief Medical Officer
Sector and Competitors